Cargando…

MiR-128 reverses the gefitinib resistance of the lung cancer stem cells by inhibiting the c-met/PI3K/AKT pathway

Gefitinib is a first line anti-tumor drug used for the treatment of patients with non-small cell lung cancer (NSCLC) harboring EGFR mutations. However, the drug resistance to gefitinib limits its clinical application. Here, we observed the CSCs of PC9 are obviously resistant to gefitinib compared wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Jingjin, Feng, Xiaoning, Zhou, Wenjing, Wu, Yue, Yang, Yunmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341972/ https://www.ncbi.nlm.nih.gov/pubmed/27690301 http://dx.doi.org/10.18632/oncotarget.12283

Ejemplares similares

The Role of miR-128 in Neurodegenerative Diseases
por: Lanza, Marika, et al.
Publicado: (2023)

miR-128-3p inhibits glioma cell proliferation and differentiation by targeting NPTX1 through IRS-1/PI3K/AKT signaling pathway
por: Huo, Leiming, et al.
Publicado: (2019)

LncRNA Bmp1 promotes the healing of intestinal mucosal lesions via the miR-128-3p/PHF6/PI3K/AKT pathway
por: Zhuang, Mengmeng, et al.
Publicado: (2021)

miR-223 reverses the resistance of EGFR-TKIs through IGF1R/PI3K/Akt signaling pathway
por: HAN, JING, et al.
Publicado: (2016)

RNA methyltransferase METTL3 induces intrinsic resistance to gefitinib by combining with MET to regulate PI3K/AKT pathway in lung adenocarcinoma
por: Gao, Fangyan, et al.
Publicado: (2021)

Inhibition of miR-19a partially reversed the resistance of colorectal cancer to oxaliplatin via PTEN/PI3K/AKT pathway
por: Zhang, Ye, et al.
Publicado: (2020)

MIR497HG‐Derived miR‐195 and miR‐497 Mediate Tamoxifen Resistance via PI3K/AKT Signaling in Breast Cancer
por: Tian, Yao, et al.
Publicado: (2023)

SNHG22 promotes migration and invasion of trophoblasts via miR-128-3p/PCDH11X axis and activates PI3K/Akt signaling pathway
por: Wei, Xiaoying, et al.
Publicado: (2022)

miR-206-3p Inhibits 3T3-L1 Cell Adipogenesis via the c-Met/PI3K/Akt Pathway
por: Tang, Renqiao, et al.
Publicado: (2017)

Role of miR-128 in hypertension-induced myocardial injury
por: Yin, Jie, et al.
Publicado: (2017)

Nanocomplexes loaded with miR-128-3p for enhancing chemotherapy effect of colorectal cancer through dual-targeting silence the activity of PI3K/AKT and MEK/ERK pathway
por: Liu, Xin, et al.
Publicado: (2020)

BYL719 reverses gefitinib-resistance induced by PI3K/AKT activation in non-small cell lung cancer cells
por: Yu, Yaya, et al.
Publicado: (2023)

MiR-128 Inhibits Tumor Growth and Angiogenesis by Targeting p70S6K1
por: Shi, Zhu-mei, et al.
Publicado: (2012)

miR‐1‐3p and miR‐206 sensitizes HGF‐induced gefitinib‐resistant human lung cancer cells through inhibition of c‐Met signalling and EMT
por: Jiao, Demin, et al.
Publicado: (2018)

Effect of miR-27b on the proliferation and apoptosis of diffuse large b-cell lymphoma cells by targeting the regulation of MET/PI3K/AKT pathway
por: Zhang, Rui, et al.
Publicado: (2022)

miR-23a binds to p53 and enhances its association with miR-128 promoter
por: Li, Jincheng, et al.
Publicado: (2015)

NAIF1 suppresses osteosarcoma progression and is regulated by miR‐128
por: Kong, Daliang, et al.
Publicado: (2018)

Simvastatin improves the homing of BMSCs via the PI3K/AKT/miR‐9 pathway
por: Bing, Weidong, et al.
Publicado: (2016)

miR-155 Regulates the Proliferation of Glioma Cells Through PI3K/AKT Signaling
por: Wu, Dahao, et al.
Publicado: (2020)

LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling
por: Liu, Hua, et al.
Publicado: (2018)

MiR-128-3p Post-Transcriptionally Inhibits WISP1 to Suppress Apoptosis and Inflammation in Human Articular Chondrocytes via the PI3K/AKT/NF-κB Signaling Pathway
por: Chen, Shujun, et al.
Publicado: (2020)

miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways
por: Sun, Xiaoyan, et al.
Publicado: (2016)

miR-128 Functions as an OncomiR for the Downregulation of HIC1 in Breast Cancer
por: Li, Yan, et al.
Publicado: (2019)

Combination therapy of gefitinib and miR-30a-5p may overcome acquired drug resistance through regulating the PI3K/AKT pathway in non-small cell lung cancer
por: Wang, Fengfeng, et al.
Publicado: (2020)

MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer
por: Li, Nana, et al.
Publicado: (2017)

miR-548x and miR-4698 controlled cell proliferation by affecting the PI3K/AKT signaling pathway in Glioblastoma cell lines
por: kalhori, Mohammad Reza, et al.
Publicado: (2020)

Effect of miR-106b on Invasiveness of Pituitary Adenoma via PTEN-PI3K/AKT
por: Zheng, Zhiming, et al.
Publicado: (2017)

Neuroprotective mechanisms of miR-124 activating PI3K/Akt signaling pathway in ischemic stroke
por: Wang, Changming, et al.
Publicado: (2017)

Propofol Inhibits Microglial Activation via miR-106b/Pi3k/Akt Axis
por: Liu, Jianhui, et al.
Publicado: (2021)

miR-128 inhibits telomerase activity by targeting TERT mRNA
por: Guzman, Herlinda, et al.
Publicado: (2018)

Inhibition of miR-128 Enhances Vocal Sequence Organization in Juvenile Songbirds
por: Aamodt, Caitlin M., et al.
Publicado: (2022)

The role of miR-128 in cancer development, prevention, drug resistance, and immunotherapy
por: Budi, Hendrik Setia, et al.
Publicado: (2023)

MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma
por: TIAN, YUAN, et al.
Publicado: (2011)

Ligand-Dependent Downregulation of Guanylyl Cyclase/Natriuretic Peptide Receptor-A: Role of miR-128 and miR-195
por: Khurana, Madan L., et al.
Publicado: (2022)

Trans‐3,5,4´‐trimethoxystilbene reduced gefitinib resistance in NSCLCs via suppressing MAPK/Akt/Bcl‐2 pathway by upregulation of miR‐345 and miR‐498
por: Lu, Min, et al.
Publicado: (2019)

Circ-CREBBP inhibits sperm apoptosis via the PI3K-Akt signaling pathway by sponging miR-10384 and miR-143-3p
por: Ding, Ning, et al.
Publicado: (2022)

miR-19a contributes to gefitinib resistance and epithelial mesenchymal transition in non-small cell lung cancer cells by targeting c-Met
por: Cao, Xiaonian, et al.
Publicado: (2017)

Regulation of colony stimulating factor-1 expression and ovarian cancer cell behavior in vitro by miR-128 and miR-152
por: Woo, Ho-Hyung, et al.
Publicado: (2012)

miR-93 Promotes Cell Proliferation in Gliomas through Activation of PI3K/Akt Signaling Pathway
por: Jiang, Lili, et al.
Publicado: (2015)

miR-494 promotes progression of retinoblastoma via PTEN through PI3K/AKT signaling pathway
por: Xu, Fen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j4qblsdbr5nlq060ccg9c8e4oh